Literature DB >> 20357785

Acute inflammatory arthritis: are glucocorticoids of benefit in very early arthritis?

Klaus Machold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20357785     DOI： 10.1038/nrrheum.2010.39

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  5 in total

1.  Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.

Authors:  Björn Svensson; Annelies Boonen; Kristina Albertsson; Désirée van der Heijde; Catharina Keller; Ingiäld Hafström
Journal:  Arthritis Rheum       Date:  2005-11

2.  The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group.

Authors:  J R Kirwan
Journal:  N Engl J Med       Date:  1995-07-20       Impact factor: 91.245

3.  The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis.

Authors:  Klaus P Machold; Robert Landewé; Josef S Smolen; Tanja A Stamm; Désirée M van der Heijde; Kirsten N Verpoort; Kerstin Brickmann; Janitzia Vázquez-Mellado; Dimitri E Karateev; Ferdinand C Breedveld; Paul Emery; Thomas W J Huizinga
Journal:  Ann Rheum Dis       Date:  2010-03       Impact factor: 19.103

4.  Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Amalia A van Everdingen; Johannes W G Jacobs; Dirk R Siewertsz Van Reesema; Johannes W J Bijlsma
Journal:  Ann Intern Med       Date:  2002-01-01       Impact factor: 25.391

5.  Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial.

Authors:  S M M Verstappen; M J McCoy; C Roberts; N E Dale; A B Hassell; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2009-10-12       Impact factor: 19.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.